STK11 mutations were also associated with a lack of PD-L1 expression [34,37] and were enriched for negative PD-L1 staining [41,42], whereas tumours with high PD-L1 (>50%) were less frequently mutated for STK11 [43]. Here, STK11 is linked to neoplasm.